These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8483545)

  • 41. Cost effectiveness--a practical approach.
    Jenkinson S
    Occup Health (Lond); 1989 Nov; 41(11):319-20. PubMed ID: 2516896
    [No Abstract]   [Full Text] [Related]  

  • 42. Economic evaluation in occupational health--its goals, challenges, and opportunities.
    Burdorf A
    Scand J Work Environ Health; 2007 Jun; 33(3):161-4. PubMed ID: 17572826
    [No Abstract]   [Full Text] [Related]  

  • 43. Audit for first aid at work.
    Rivett J
    Occup Health (Lond); 1988 Apr; 40(4):516-9. PubMed ID: 3133618
    [No Abstract]   [Full Text] [Related]  

  • 44. Using blackmail tactics on flu vaccinations is unacceptable.
    Harrison M
    Nurs Stand; 2013 Oct 2-8; 28(5):35. PubMed ID: 24093413
    [No Abstract]   [Full Text] [Related]  

  • 45. A guide to conducting an economic evaluation of an occupational health program.
    Chovil A; Jacobs P
    Occup Health Nurs; 1983 Feb; 31(2):37-40. PubMed ID: 6402743
    [No Abstract]   [Full Text] [Related]  

  • 46. Is safety progress slowed by HSC cost/benefit policy?
    Booth RT
    Occup Health (Lond); 1983 Jan; 35(1):35-7. PubMed ID: 6405334
    [No Abstract]   [Full Text] [Related]  

  • 47. Selling OH. An uphill struggle.
    Mossman D; Purnell C
    Occup Health (Lond); 1986 Aug; 38(8):248-50. PubMed ID: 3093946
    [No Abstract]   [Full Text] [Related]  

  • 48. Cost benefit vs. cost effectiveness--a new game plan for a new millennium?
    D'Auria D
    Occup Med (Lond); 1998 Apr; 48(3):151. PubMed ID: 9659723
    [No Abstract]   [Full Text] [Related]  

  • 49. Toward a positive contribution to understanding cost-effectiveness issues in the surveillance and prevention of occupational disease.
    Geidenberger CA; Nestel G; Socie EM
    Am J Ind Med; 1999 Apr; 35(4):432-3. PubMed ID: 10086205
    [No Abstract]   [Full Text] [Related]  

  • 50. What is the most cost-effective way to identify silica problem worksites?
    Rosenman KD
    Am J Ind Med; 1999 Apr; 35(4):434-5. PubMed ID: 10086206
    [No Abstract]   [Full Text] [Related]  

  • 51. To model or not to model: lessons from two vaccinations.
    Garattini L; Padula A
    Eur J Health Econ; 2011 Jun; 12(3):189-91. PubMed ID: 21267623
    [No Abstract]   [Full Text] [Related]  

  • 52. A year of heightened awareness for OH. Interview by Helen Kogan.
    Hammer J
    Occup Health (Lond); 1992 Mar; 44(3):75-6. PubMed ID: 1560965
    [No Abstract]   [Full Text] [Related]  

  • 53. The Dental Team: An Additional Resource for Delivering Vaccinations.
    Serban S; Mustufvi Z; Kang J; Simon SE; Grant S; Douglas G
    Front Med (Lausanne); 2020; 7():606242. PubMed ID: 33240912
    [No Abstract]   [Full Text] [Related]  

  • 54. Corrigendum: The Dental Team: An Additional Resource for Delivering Vaccinations.
    Serban S; Mustufvi Z; Kang J; Simon SE; Grant S; Douglas G
    Front Med (Lausanne); 2021; 8():653861. PubMed ID: 33842511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Helen Salisbury: Keeping vaccinations local.
    Salisbury H
    BMJ; 2021 Jan; 372():n145. PubMed ID: 33468522
    [No Abstract]   [Full Text] [Related]  

  • 56. South Korea to continue flu vaccinations after 25 deaths trigger calls for a pause.
    Dyer O
    BMJ; 2020 Oct; 371():m4116. PubMed ID: 33097486
    [No Abstract]   [Full Text] [Related]  

  • 57. Helen Salisbury: Older lives are not worth less.
    Salisbury H
    BMJ; 2020 Oct; 371():m3915. PubMed ID: 33051182
    [No Abstract]   [Full Text] [Related]  

  • 58. Helen Salisbury: Who let the drug companies in?
    Salisbury H
    BMJ; 2019 Apr; 365():l1581. PubMed ID: 30971401
    [No Abstract]   [Full Text] [Related]  

  • 59. Dividend at 100 percent a Year.
    Wolfle D
    Science; 1955 Sep; 122(3170):581. PubMed ID: 17776598
    [No Abstract]   [Full Text] [Related]  

  • 60. Potential Economic Benefits of Paid Sick Leave in Reducing Absenteeism Related to the Spread of Influenza-Like Illness.
    Asfaw A; Rosa R; Pana-Cryan R
    J Occup Environ Med; 2017 Sep; 59(9):822-829. PubMed ID: 28692009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.